The indigenous intra-nasal vaccine, Nasovac is finally released to the market. It takes just two puffs in each nostril to control the deadly H1N1 virus. The vaccine is free of side effects and can be administered to anybody, except pregnant woman and children below three years.
Pune based Serum Institute of India created Nasovac the first WHO approved nasal vaccine which is administered without a needle and pain-free. Clinical trials have shown it is as effective as an injection. Infact , it is even more effective as the nasal spray blocks the virus at the entry itself.
The vaccine was launched a couple of weeks ago across India. About a half million doses have been released so far. Already more than 2 lakh people have bought it, mainly in Pune and Mumbai, where the virus is creating panic.
It costs about Rs.250 and is now available with leading chemists. The vaccine provides life time immunity .To be on safer side it is recommended that the vaccine should be taken every year.
The central government has so far been importing Swine Flu vaccines from French drug maker Sanofi Pasteur , used mainly for inoculating health workers. The country’s first indigenous vaccine VaxiFlu-S, in an injection form, was recently launched by Ahmadabad based ZydusCadilla.
No comments:
Post a Comment